Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-12-08 Sale | 2022-12-12 1:39 pm | Virios Therapeutics Inc. | VIRI | Whitley Richard James Director | 1,800 | $0.2591 | $466 | 700 (Direct) | View |
2022-05-23 Purchase | 2022-05-24 2:53 pm | Virios Therapeutics Inc. | VIRI | Walsh Angela SVP OF FINANCE | 2,000 | $4.575 | $9,150 | 3,000 (Indirect) | View |
2022-05-23 Purchase | 2022-05-24 10:24 am | Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | 7,500 | $4.52 | $33,900 | 32,461 (Direct) | View |
2022-05-18 Purchase | 2022-05-19 11:48 am | Virios Therapeutics Inc. | VIRI | Whitley Richard James Director | 500 | $4.525 | $2,263 | 2,500 (Direct) | View |
2022-05-18 Purchase | 2022-05-19 11:44 am | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 241 | $4.5 | $1,085 | 745,944 (Indirect Direct) | View |
2022-05-17 Purchase | 2022-05-18 11:24 am | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 13,450 | $4.3802 | $58,914 | 745,703 (Indirect Direct) | View |
2022-03-29 Purchase | 2022-03-30 11:55 am | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 600 | $4.9408 | $2,964 | 732,253 (Indirect Direct) | View |
2022-03-23 Purchase | 2022-03-24 2:52 pm | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 2,197 | $5.4627 | $12,002 | 731,653 (Indirect Direct) | View |
2022-01-27 Purchase | 2022-01-28 3:30 pm | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 4,180 | $5.9803 | $24,998 | 729,456 (Indirect Direct) | View |
2022-01-07 Purchase | 2022-01-07 5:24 pm | Virios Therapeutics Inc. | VIRI | De La Rosa Abel Director | 4,000 | $5.896 | $23,584 | 4,000 (Direct) | View |
2022-01-06 Purchase | 2022-01-07 1:14 pm | Virios Therapeutics Inc. | VIRI | Whitley Richard James Director | 1,800 | $5.72 | $10,296 | 2,000 (Direct) | View |
2022-01-04 Purchase | 2022-01-05 3:12 pm | Virios Therapeutics Inc. | VIRI | Keefer David R Director | 5,000 | $5.795 | $28,975 | 12,808 (Indirect Direct) | View |
2022-01-03 Purchase | 2022-01-04 3:23 pm | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 2,215 | $5.4329 | $12,034 | 725,276 (Indirect Direct) | View |
2022-01-04 Purchase | 2022-01-04 3:19 pm | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 1,000 | $5.65 | $5,650 | 1,000 (Direct) | View |
2021-12-23 Purchase | 2021-12-23 3:59 pm | Virios Therapeutics Inc. | VIRI | Whitley Richard James Director | 200 | $5.725 | $1,145 | 200 (Direct) | View |
2021-12-21 Purchase | 2021-12-22 1:28 pm | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 8,827 | $5.6641 | $49,997 | 723,061 (Indirect Direct) | View |
2021-12-21 Purchase | 2021-12-22 1:23 pm | Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | 5,000 | $5.523 | $27,615 | 24,961 (Direct) | View |
2021-07-07 Purchase | 2021-07-09 1:36 pm | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 942 | $6.317 | $5,951 | 714,234 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-12-12 Option Award(A) | 2023-02-15 12:54 pm | N/A 2032-12-12 | Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | 410,000 | $0 | 410,000 (Direct) | View |
2022-12-12 Option Award | 2022-12-14 6:33 pm | N/A 2032-12-12 | Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | 480,000 | $0 | 480,000 (Direct) | View |
2022-12-12 Option Award | 2022-12-14 6:32 pm | N/A 2032-12-12 | Virios Therapeutics Inc. | VIRI | Walsh Angela SVP OF FINANCE | 80,000 | $0 | 80,000 (Direct) | View |
2022-12-12 Option Award | 2022-12-14 6:31 pm | N/A 2032-12-12 | Virios Therapeutics Inc. | VIRI | Grosswald Ralph SVP OF OPERATIONS | 80,000 | $0 | 80,000 (Direct) | View |
2022-12-12 Option Award | 2022-12-14 6:30 pm | N/A 2032-12-12 | Virios Therapeutics Inc. | VIRI | Gendreau Roger Michael CHIEF MEDICAL OFFICER | 80,000 | $0 | 80,000 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 2:09 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Whitley Richard James Director | 5,250 | $0 | 5,250 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 2:08 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 5,250 | $0 | 5,250 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 2:05 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Burch Richard Alan Director | 5,250 | $0 | 5,250 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 2:03 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Keefer David R Director | 5,250 | $0 | 5,250 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 2:01 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 5,250 | $0 | 5,250 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 1:59 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | De La Rosa Abel Director | 5,250 | $0 | 5,250 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 1:53 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Gendreau Roger Michael CHIEF MEDICAL OFFICER | 40,000 | $0 | 40,000 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 1:43 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Grosswald Ralph SVP OF OPERATIONS | 40,000 | $0 | 40,000 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 1:40 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Walsh Angela SVP OF FINANCE | 40,000 | $0 | 40,000 (Direct) | View |
2022-06-23 Option Award | 2022-06-30 1:38 pm | N/A 2032-06-23 | Virios Therapeutics Inc. | VIRI | Duncan Gregory Scott CHIEF EXECUTIVE OFFICER | 90,000 | $0 | 90,000 (Direct) | View |
Ownership | 2022-02-14 3:03 pm | N/A N/A | Virios Therapeutics Inc. | VIRI | Burch Richard Alan Director | 0 | $0 | 147,681 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 3:26 pm | N/A 2031-06-22 | Virios Therapeutics Inc. | VIRI | Pridgen William Director | 7,875 | $0 | 7,875 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 2:59 pm | N/A 2031-06-22 | Virios Therapeutics Inc. | VIRI | Burch Richard Alan Director | 7,875 | $0 | 7,875 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 2:55 pm | N/A 2031-06-22 | Virios Therapeutics Inc. | VIRI | Whitley Richard James Director | 7,875 | $0 | 7,875 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 2:52 pm | N/A 2031-06-22 | Virios Therapeutics Inc. | VIRI | Thomas John C Director | 7,875 | $0 | 7,875 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 2:48 pm | N/A 2031-06-22 | Virios Therapeutics Inc. | VIRI | Keefer David R Director | 7,875 | $0 | 7,875 (Direct) | View |
2021-06-22 Option Award | 2021-06-23 2:42 pm | N/A 2031-06-22 | Virios Therapeutics Inc. | VIRI | De La Rosa Abel Director | 7,875 | $0 | 7,875 (Direct) | View |